Reliv International (RELV)

Overall impact
B (70)

Commentary

Reliv International is a strong overall performer. With a 'B' rating of 69.9 for overall impact (82nd percentile compared to all companies), Reliv International ranks 2nd out of 22 industry peers, behind Danone, and ahead of David's Tea, Grupo Nutresa, Lifeway Foods and 17 others. On top material causes for Reliv International's industry (Food), Reliv International performs well in Sustainable Use of Water (85.5 score), Fair Labor Practices (95.6), Child and Maternal Health (87.7) and 4 other causes where it received an 'A' score and performs poorly in Child and Maternal Health (35.8 score), Zero Hunger (37.6) and Disaster Readiness and Effective Aid (31.8).
Impact
Cause RELV
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
91
Sector
Consumer Staples
Industry
Food Products
Sub-industry
Packaged Foods & Meats
SASB industry
Processed Foods
Headquarters
Mo, United States
Share classes
RELV
Description
Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.
Material causes
Ethos considers the following causes material for Reliv International, based on its industry sub-industry Packaged Foods & Meats. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.